Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02282306 · ClinicalTrials.gov registry record · NA
Phone Interview to Prevent Recurring Opioid Overdoses
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02282306 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 30 participants.
The verdict
NCT02282306, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
There has been a dramatic rise in opioid overdose (OOD) deaths in recent years. Attempts to ameliorate the problem have largely focused on increasing the accessibility of naloxone, an opioid antagonist that is effective in OOD reversal. Individuals who have experienced a non-fatal OOD are at risk for additional overdoses and yet there are no interventions that specifically target this high-risk population. To address this gap, the investigators have developed the "Tailored Telephone Intervention delivered by Peers to Prevent Recurring Opioid Overdoses" (TTIP-PRO). The overall goal of the present study is to conduct a pilot evaluation of the TTIP-PRO. The research literature suggests the need for an intervention targeting patients experiencing a non-fatal OOD.
Interventions
- BEHAVIORAL TTIP-PRO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02282306
The ClinicalTrials.gov registry entry for NCT02282306 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TTIP-PRO is the first listed.
NCT02282306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02282306 about?
NCT02282306 is a clinical study titled "Phone Interview to Prevent Recurring Opioid Overdoses". There has been a dramatic rise in opioid overdose (OOD) deaths in recent years. Attempts to ameliorate the problem have largely focused on increasing the accessibility of naloxone, an opioid antagonist that is effective in OOD reversal. Individuals who have experienced a non-fatal OOD are at risk fo...
What is the current status of trial NCT02282306?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-09. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02282306?
The interventions under investigation include: TTIP-PRO (BEHAVIORAL).
Who is sponsoring clinical trial NCT02282306?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.